Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126647861 | 12664786 | 1 | I | 20160810 | 20160818 | 20160818 | EXP | AU-PFIZER INC-2016385020 | PFIZER | CLANCY, D. POTENTIAL ABUSE FROM UNEXPECTED SOURCES (PART 2). AUSTRALIAN PHARMACIST. 2016;AUGUST:67-69 | 0.00 | M | Y | 0.00000 | 20160818 | PH | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126647861 | 12664786 | 1 | PS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 2100 MG, DAILY | U | 20699 | 2100 | MG | ||||||||
| 126647861 | 12664786 | 2 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 3750 MG, DAILY | U | 20699 | 3750 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126647861 | 12664786 | OT |
| 126647861 | 12664786 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126647861 | 12664786 | Central nervous system stimulation | |
| 126647861 | 12664786 | Dizziness | |
| 126647861 | 12664786 | Drug withdrawal syndrome | |
| 126647861 | 12664786 | Muscular weakness | |
| 126647861 | 12664786 | Tremor | |
| 126647861 | 12664786 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |